Geoffrey D. Barnes

3 weeks ago | healio.com | Scott Buzby |Richard Smith |Geoffrey D. Barnes |Isabelle Mahé

Low-dose apixaban for extended anticoagulation may be option for preventing cancer-related VTE• Continued anticoagulation is recommended for patients with active cancer and/or ongoing cancer treatment. • Extended treatment with low-dose apixaban was noninferior to a full dose for preventing cancer-related VTE.

Jul 1, 2024 | acpjournals.org | Geoffrey D. Barnes

Get full access to this articleView all available purchase options and get full access to this article. Supplemental MaterialAuthor Disclosures (annals-24-00652-jc_supplement-disclosureforms.pdf)Reference1. Writing Committee Members; Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Mar 20, 2024 | nature.com | Azita H. Talasaz |Parham Sadeghipour |John Eikelboom |Deborah M. Siegal |Manuel Monreal |David Jimenez | +8 more

AbstractBalancing the safety and efficacy of antithrombotic agents in patients with gastrointestinal disorders is challenging because of the potential for interference with the absorption of antithrombotic drugs and for an increased risk of bleeding. In this Review, we address considerations for enteral antithrombotic therapy in patients with cardiovascular disease and gastrointestinal comorbidities.

Mar 20, 2024 | nature.com | Azita H. Talasaz |Parham Sadeghipour |John Eikelboom |Deborah M. Siegal |Manuel Monreal |David Jimenez | +8 more

AbstractBalancing the safety and efficacy of antithrombotic agents in patients with gastrointestinal disorders is challenging because of the potential for interference with the absorption of antithrombotic drugs and for an increased risk of bleeding. In this Review, we address considerations for enteral antithrombotic therapy in patients with cardiovascular disease and gastrointestinal comorbidities.

Jun 10, 2023 | jahonline.org | Steven Cook |Geoffrey D. Barnes |Douglas Arenberg

Cookie Preference CenterWe use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our Cookie Policy and the list of Google Ad-Tech Vendors. You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer.